Mentioned On
Episode Mentions
Motley Fool Money · Apr 12, 2026
The Psychedelic Revolution
“Publicly traded psychedelic biotech (CNPS) advancing phase 3 trials for COMP360 psilocybin treatment with recent 23% stock jump”
Psychedelic-Assisted Therapy Clinical EfficacyTreatment-Resistant Depression Market OpportunityFDA Approval Pathways for Psychedelic Compounds
View Analysis